HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells.

Ma, Quanfeng; Wang, Xiuyu; Wang, Hong; Song, Wen; Wang, Qiong; Wang, Jinhuan

Ma, Quanfeng; Wang, Xiuyu; Wang, Hong; Song, Wen; Wang, Qiong; Wang, Jinhuan.

Affiliation

Ma Q; Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin 300350, China.
Wang X; The Graduate School, Tianjin Medical University, Tianjin 300070, China.
Wang H; Department of Neurosurgery, Tianjin First Center Hospital, Tianjin 300192, China.
Song W; Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin 300350, China.
Wang Q; The Graduate School, Tianjin Medical University, Tianjin 300070, China.
Wang J; Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin 300350, China.

Biomed Res Int ; 2020: 8610271, 2020.

Article de En | MEDLINE | ID: mdl-32596388

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transactivateurs / Glioblastome / Système de signalisation des MAP kinases / Protéines HMGN Limites: Animals / Humans / Male Langue: En Journal: Biomed Res Int Année: 2020 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google